Use of Recombinant Factor VIIa for Refractory Hemorrhage During Extracorporeal Membrane Oxygenation
To describe the outcome and treatment of two patients with recombinant factor VIIa (rFVIIa) for severe hemorrhage associated with extracorporeal membrane oxygenation (ECMO).